Looking beyond anti-TNF in IBD: Vedolizumab, tofacitinib, etc.

Premium Content

Please purchase any of the premium collections shown to access this library item.

View all of your premium content purchases in myUEG > My Learning.
If you need help or have questions, please contact e-learning@ueg.eu

This item was part of the Therapy update: Best use of biologics in IBD in 2014 session at UEG Week 2014